Lehrstuhl für Haut- und Geschlechtskrankheiten

S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma – short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality-of-care indicators (2020) Heppt MV, Leiter U, Steeb T, Amaral T, Bauer A, Becker JC, Breitbart E, et al. Journal article S3-Leitlinie „Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Kurzfassung, Teil 1: Diagnostik, Interventionen bei aktinischen Keratosen, Versorgungsstrukturen und Qualitätsindikatoren (2020) Heppt MV, Leiter U, Steeb T, Amaral T, Bauer A, Becker JC, Breitbart E, et al. Journal article Blood eosinophilia is an on-treatment biomarker in patients with solid tumors undergoing dendritic cell vaccination with autologous tumor-RNA (2020) Moreira A, Erdmann M, Uslu U, Vass V, Schuler G, Schuler-Thurner B Journal article Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermany (2020) Heratizadeh A, Haufe E, Stoelzl D, Abraham S, Heinrich L, Kleinheinz A, Wollenberg A, et al. Journal article Loading of Primary Human T Lymphocytes with Citrate-Coated Superparamagnetic Iron Oxide Nanoparticles Does Not Impair Their Activation after Polyclonal Stimulation (2020) Mühlberger M, Unterweger H, Band J, Lehmann C, Heger L, Dudziak D, Alexiou C, et al. Journal article Serio - Side Effect Registry in Immuno-Oncology (2020) Koutzamanidis R, Mentzer D, Knauss S, Broeckelmann PJ, Hassel JC, Ugurel-Becker S, Pavel ME, et al. Conference contribution Multiplex Tissue Analysis of the Tumor Microenvironment and Crucial Factors in Melanoma Pathogenesis (2020) Ostalecki C, Lee JH, Schierer S, Collenburg L, Schuler G, Baur A Conference contribution EMT transcription factor ZEB1 alters the epigenetic landscape of colorectal cancer cells (2020) Lindner P, Paul S, Eckstein M, Hampel C, Muenzner JK, Erlenbach-Wuensch K, Ahmed HP, et al. Journal article Itching and Neurodermatitis: Results from the German Neurodermatitis Register TREATgermany (2020) Haufe E, Heinrich L, Weisshaar E, Abraham S, Heratizadeh A, Harder I, Kleinheinz A, et al. Conference contribution Insights From the Apremilast After Switching From Fumaric Acid Ester Treatment (APART) Study: An Interim Real-World Safety Analysis (2020) Mrowietz U, Ertner K, Sticherling M, Grosse V, Popp G, Schwichtenberg U, Karl L, et al. Conference contribution